Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9196 posts found.

Vertex shares results from phase 1/2 trial of type 1 diabetes treatment

June 24, 2024 Research and Development Diabetes, Vertex pharmaceuticals, clinical trial, diabetes

Vertex Pharmaceuticals has announced new data from its phase 1/2 clinical trial of VX-880, an investigational stem cell-derived, fully differentiated …
News

Gilead shares phase 3 results from HIV prevention trial

June 21, 2024 Research and Development Gilead, HIV, Infections and infestations, clinical trial

Gilead Sciences has announced results from an interim analysis of its pivotal, phase 3 PURPOSE 1 trial, which assessed the …
News

Takeda shares data from phase 3 trial of CIPD treatment

June 20, 2024 Research and Development CIDP, Hyqvia, Neurology, Takeda, clinical trial

Takeda has announced data from the phase 3 ADVANCE-CIDP 3 trial, which assessed the safety and efficacy of Hyqvia (Immune …
News

First patient dosed in Assembly Biosciences’ phase 1b trial for hepatitis B treatment

June 19, 2024 Research and Development Assembly Biosciences, Hepatology, clinical trial, hepatitis

Assembly Biosciences has announced that the first participant has been dosed in its phase 1b trial of ABI-4334, the company’s …
News

Innate Pharma shares results from phase 1/2 trial for blood cancer treatment

June 17, 2024 Research and Development Innate Pharma, Oncology, blood cancer, clinical trial

Innate Pharma has announced updated efficacy and safety results from the dose-escalation part of the phase 1/2 study with SAR443579/IPH6101 …
News

AbbVie and FutureGen announce license agreement for IBD therapy

June 14, 2024 Research and Development FutureGen, Gastrointestinal tract, ibd, inflammatory bowel disease

AbbVie and FutureGen Biopharmaceutical have announced a license agreement for the development of FG-M701, a next-generation TL1A antibody for the …
News

Pfizer shares update on DMD gene therapy clinical trial

June 13, 2024 Research and Development DMD, Musculo-skeletal disorder, Pfizer, duchenne muscular dystropy, gene therapy

Pfizer has announced an update from its phase 3 randomised, multicentre, double-blind, placebo-controlled CIFFREO trial, which assessed the investigational mini-dystrophin …
News

Cara Therapeutics shares data from part a of notalgia paresthetica trial

June 13, 2024 Research and Development Cara Therapeutics, Neurology, clinical trial, notalgia paresthetica, pruritus

Cara Therapeutics has announced the outcome from the dose-finding Part A of the KOURAGE-1 study which assessed the efficacy and …
News

Evotec shares progress in Bristol Myers Squibb neuroscience collaboration

June 12, 2024 Research and Development Evotec, Neurology, bristol myers squibb, neuroscience

Evotec has announced that it has reached important scientific progress within the neuroscience collaboration with Bristol Myers Squibb, initiating a …
News

Eli Lilly shares results for tirzepatide for MASH resolution

June 10, 2024 Research and Development Eli Lilly, Hepatology, MASH, clinical trial, liver

Eli Lilly has announced results from the phase 2 SYNERGY-NASH study which assessed 190 patients, with or without type 2 …
News

Nuclera gains £1.14m funding from Innovate UK

June 7, 2024 Research and Development Innovate UK, Nuclera, Pharmacy, grants

Nuclera has announced that it has been awarded two grants from Innovate UK, totalling £1.14m.
News

Syngene launches new platform for protein production

June 6, 2024 Research and Development ExcellGene, Pharmacy, Syngene, platform, protein production

Syngene has announced the launch of its new protein production platform, which will utilise a cell line and transposon-based technology …
News

Gilead shares results from two-year analysis of phase 3 study in primary biliary cholangitis

June 5, 2024 Research and Development Gilead, Hepatology, clinical trials, primary biliary cholangitis, seladelpar

Gilead has announced two-year interim results from the ongoing ASSURE study of investigational seladelpar for the treatment of primary biliary …
News
testalize-me-0je8ynv4mis-unsplash

Sanofi shares phase 3 trial results for Sarclisa in multiple myeloma treatment

June 5, 2024 Research and Development Oncology, Sanofi, Sarclisa, clinical trial, multiple myeloma

Sanofi has announced data from the IMROZ phase 3 trial which assessed Sarclisa (isatuximab) in combination with standard-of-care bortezomib, lenalidomide …
News

Gilead and Arcus announce results from colorectal cancer treatment trial

June 3, 2024 Research and Development Arcus, Gilead, Oncology, clinical trial, colorectal cancer

Gilead Sciences and Arcus Biosciences have announced new data from cohort B of ARC-9, a phase 1b/2 study which aims …
News

Latest content

AstraZeneca’s Tagrisso approved in Japan for lung cancer treatment

June 25, 2024

ILiAD Biotechnologies announces collaboration with Emmes Group on phase 3 pertussis vaccine trial

June 25, 2024

GSK’s Jemperli accepted for review by EMA for endometrial cancer treatment

June 24, 2024

Vertex shares results from phase 1/2 trial of type 1 diabetes treatment

June 24, 2024

Gilead shares phase 3 results from HIV prevention trial

June 21, 2024